For the year ending 2025-12-31, VOR has $464,126K in assets. $628,438K in debts. $396,486K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 396,486 | |||
| Marketable securities | 58,722 | |||
| Prepaid expenses | 1,152 | |||
| Other current assets | 1,745 | |||
| Total current assets | 458,105 | |||
| Restricted cash equivalents | 168 | |||
| Property and equipment, net | 533 | |||
| Operating lease right-of-use assets | 2,936 | |||
| Other assets | 2,384 | |||
| Total assets | 464,126 | |||
| Accounts payable | 5,127 | |||
| Accrued liabilities | 19,764 | |||
| Operating lease liabilities | 280 | |||
| Total current liabilities | 25,171 | |||
| Operating lease liabilitiesnon-current | 2,720 | |||
| Warrant liabilities | 600,547 | |||
| Total liabilities | 628,438 | |||
| Common stock, 0.0001 par value 800,000,000 and 400,000,000 shares authorized as of december 31, 2025 and december 31, 2024, respectively 38,720,196 and 6,238,799 shares issued and outstanding as of december 31, 2025 and december 31, 2024, respectively | 18 | |||
| Additional paid-in capital | 988,604 | |||
| Accumulated other comprehensive income | 41 | |||
| Accumulated deficit | -1,152,975 | |||
| Total stockholders' equity (deficit) | -164,312 | |||
| Total liabilities and stockholders' equity (deficit) | 464,126 | |||
Vor Biopharma Inc. (VOR)
Vor Biopharma Inc. (VOR)